“Aprepitant, a novel neurokinin-1 receptor antagonist in management of chemotherapy induces nausea vomiting (CINV) in cancer patients” (2019) International Journal of Research in Clinical and Hospital Pharmacy, 2(1), pp. 1–4. Available at: https://rubatosis.org/journals/index.php/ijrhcp/article/view/144 (Accessed: 19 April 2025).